ATE297714T1 - Formulierungen mit verlängerter freisetzung zur implantation - Google Patents

Formulierungen mit verlängerter freisetzung zur implantation

Info

Publication number
ATE297714T1
ATE297714T1 AT00970216T AT00970216T ATE297714T1 AT E297714 T1 ATE297714 T1 AT E297714T1 AT 00970216 T AT00970216 T AT 00970216T AT 00970216 T AT00970216 T AT 00970216T AT E297714 T1 ATE297714 T1 AT E297714T1
Authority
AT
Austria
Prior art keywords
particles
carbonate
substance
implantation
acid
Prior art date
Application number
AT00970216T
Other languages
English (en)
Inventor
Akihiko Sano
Masako Ishikawa
Hiroo Maeda
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of ATE297714T1 publication Critical patent/ATE297714T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00970216T 1999-11-10 2000-10-31 Formulierungen mit verlängerter freisetzung zur implantation ATE297714T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31910899 1999-11-10
PCT/JP2000/007639 WO2001034112A1 (en) 1999-11-10 2000-10-31 Sustained-release drug formulations for implantation

Publications (1)

Publication Number Publication Date
ATE297714T1 true ATE297714T1 (de) 2005-07-15

Family

ID=18106562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00970216T ATE297714T1 (de) 1999-11-10 2000-10-31 Formulierungen mit verlängerter freisetzung zur implantation

Country Status (16)

Country Link
US (2) US7247312B1 (de)
EP (1) EP1229900B1 (de)
KR (1) KR100772948B1 (de)
CN (1) CN1170523C (de)
AT (1) ATE297714T1 (de)
AU (1) AU778359B2 (de)
BR (1) BR0015422B1 (de)
CA (1) CA2384301C (de)
DE (1) DE60020871T2 (de)
ES (1) ES2243311T3 (de)
MX (1) MXPA02004711A (de)
NZ (1) NZ518252A (de)
PT (1) PT1229900E (de)
TW (1) TW524696B (de)
WO (1) WO2001034112A1 (de)
ZA (1) ZA200202402B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
WO2006138719A2 (en) 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
EP2608772A2 (de) * 2010-08-23 2013-07-03 President and Fellows of Harvard College Partikel für wirkstofffreisetzung und andere anwendung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US4191741A (en) 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
US5417985A (en) * 1989-07-20 1995-05-23 Farmalyoc Solid and porous single dosage form comprising particles in the form of beads and its preparation
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
JP2818892B2 (ja) 1989-10-02 1998-10-30 大塚製薬 株式会社 発泡製剤
JP3720386B2 (ja) 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
WO1997022409A1 (en) * 1995-12-21 1997-06-26 Drexel University Hollow polymer microcapsules and method of producing
AU6946198A (en) * 1997-04-01 1998-10-22 Cap Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations

Also Published As

Publication number Publication date
MXPA02004711A (es) 2002-09-02
CA2384301C (en) 2009-05-12
DE60020871T2 (de) 2006-05-11
US7247312B1 (en) 2007-07-24
BR0015422B1 (pt) 2012-09-04
US7601363B2 (en) 2009-10-13
ZA200202402B (en) 2003-05-28
AU7963900A (en) 2001-06-06
CN1387428A (zh) 2002-12-25
KR20020059617A (ko) 2002-07-13
BR0015422A (pt) 2002-07-16
CA2384301A1 (en) 2001-05-17
NZ518252A (en) 2003-10-31
AU778359B2 (en) 2004-12-02
DE60020871D1 (de) 2005-07-21
US20070166377A1 (en) 2007-07-19
ES2243311T3 (es) 2005-12-01
WO2001034112A1 (en) 2001-05-17
CN1170523C (zh) 2004-10-13
EP1229900B1 (de) 2005-06-15
TW524696B (en) 2003-03-21
PT1229900E (pt) 2005-08-31
KR100772948B1 (ko) 2007-11-02
EP1229900A1 (de) 2002-08-14

Similar Documents

Publication Publication Date Title
HU9600574D0 (en) Multiple unit pharmaceutical preparation containing proton pump inhibitor
NZ513810A (en) Compositions and methods for improved delivery of hydrophobic therapeutic agents
DE50211045D1 (de) Medizinische aerosolformulierungen
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
AR029623A1 (es) Composiciones farmaceuticas de eritropoyetina
DE50110049D1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
ATE427925T1 (de) Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
EP0974350A4 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DE59903959D1 (de) Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Vefahren zu deren Herstellung
EE200100433A (et) Klaritromütsiini, rasv- ja hüdrofiilse komponendisegu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine
PL341033A1 (en) Agent for treating creatine fibre
DE60020871D1 (de) Formulierungen mit verlängerter freisetzung zur implantation
MXPA04000211A (es) Granulados que contienen substancias liposolubles y un proceso para la preparacion de los mismos.
ES2111149T3 (es) Extracto a base de proteinas bacterianas, procedimiento para su preparacion y composicion farmaceutica que lo contiene.
ITMI20022549A1 (it) Composizione quaternaria comprendente come sostanza attiva la propolis.
PT1186292E (pt) Preparados solidos com estrutura multinuclear
GB9902527D0 (en) Compositions
AR026436A1 (es) Formulaciones de drogas de liberacion sostenida
ES2196689T3 (es) Granulado efervescente con efervescencia retardada.
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
AR023355A1 (es) Procedimiento de preparacion de globulos con un contenido >/= 50% en peso de sustancia activa farmaceutica
BG102055A (en) Method for the manufacture of pest control preparations with sulphur as an active substance
BG101704A (en) Gametotoxic formulation
AU6877687A (en) Slow release formulations

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1229900

Country of ref document: EP